Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy. 1994

K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.

The dystrophin-glycoprotein complex spans the sarcolemma to provide a linkage between the subsarcolemmal cytoskeleton and the extracellular matrix in skeletal muscle. In Duchenne muscular dystrophy (DMD), the absence of dystrophin leads to a drastic reduction in all of the dystrophin-associated proteins in the sarcolemma, thus causing the disruption of the dystrophin-glycoprotein complex and the loss of the linkage to the extracellular matrix. This is presumed to lead to sarcolemmal instability which could render muscle fibers susceptible to necrosis. In DMD, a very small percentage of muscle fibers show dystrophin staining along the sarcolemma, presumably due to a second in-frame deletion in the dystrophin gene. However, the functional significance of these rare dystrophin-positive muscle fibers (revertants) in DMD has been unclear. Here we report the co-expression of the dystrophin-associated proteins with dystrophin in revertants of DMD skeletal muscle. Our results suggest that the entire dystrophin-glycoprotein complex is restored in revertants and, thus, the linkage between the subsarcolemmal cytoskeleton and the extracellular matrix is restored in these muscle fibers.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings
D016189 Dystrophin A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.
D049030 Dystroglycans Dystrophin-associated proteins that play role in the formation of a transmembrane link between laminin-2 and DYSTROPHIN. Both the alpha and the beta subtypes of dystroglycan originate via POST-TRANSLATIONAL PROTEIN PROCESSING of a single precursor protein. Dystroglycan,Cranin,Dystroglycan 1,Dystrophin-Associated Glycoprotein 1,alpha-Dystroglycan,beta-Dystroglycan,Dystrophin Associated Glycoprotein 1,alpha Dystroglycan,beta Dystroglycan

Related Publications

K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
July 1995, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
January 1992, Neuromuscular disorders : NMD,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
October 1994, Journal of the neurological sciences,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
March 1995, Journal of the neurological sciences,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
January 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
October 1996, Acta neuropathologica,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
April 1993, Neurology,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
April 2021, Genome medicine,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
January 1990, Rinsho shinkeigaku = Clinical neurology,
K Matsumura, and F M Tomé, and H Collin, and F Leturcq, and M Jeanpierre, and J C Kaplan, and M Fardeau, and K P Campbell
February 1985, Rinsho shinkeigaku = Clinical neurology,
Copied contents to your clipboard!